Integrating Bioinformatics, AI, Imaging, and Clinical Informatics in Cancer Research
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Informatics and Big Data".
Deadline for manuscript submissions: 5 February 2025 | Viewed by 63
Special Issue Editor
Special Issue Information
Dear Colleagues,
Bioinformatics and artificial intelligence (AI) are reshaping cancer research, offering unprecedented opportunities to enhance our understanding and treatment of this complex disease.
We invite contributions that employ multi-omics, single-cell RNA sequencing (scRNAseq), spatial transcriptomic profiling, functional genomics screening, and advanced imaging techniques, including cell imaging and histology imaging, in the context of cancer research. These methodologies have transformative potential, enabling researchers to uncover new cellular subtypes, elucidate complex molecular pathways, and map tumor microenvironments in unprecedented detail.
This Special Issue also encourages work that spans the disciplines of bioinformatics, medical imaging, clinical informatics, and generative artificial intelligence, including large language models. Enhanced integrative approaches across these fields will foster advancements in cancer prognosis, diagnosis, therapy, and fundamental research. This Special Issue contributes towards the convergence of all aspects of cancer informatics by embracing traditionally cross-disciplinary topics in a unified collection.
Dr. Jason Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- multiomics
- genomics
- transcriptomics artificial intelligence
- deep learning
- clinical informatics
- medical imaging
- functional genomics
- multi-discipline
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
